In 2022, Poland reported 330.5 deaths from cancer per 100,000 population, the highest cancer mortality rate in Europe. Hungary followed with 327.8 cancer deaths per 100,000, and then Croatia with 319.6 cancer deaths per 100,000 population. This statistic displays the cancer mortality rate in Europe in 2022, by country (per 100,000 population).
In 2022, the highest cancer rate for men and women among European countries was in Denmark with 728.5 cancer cases per 100,000 population. Ireland and the Netherlands followed, with 641.6 and 641.4 people diagnosed with cancer per 100,000 population, respectively.
Lung cancer
Lung cancer is the deadliest type of cancer worldwide, and in Europe, Germany was the country with the highest number of lung cancer deaths in 2022, with 47.7 thousand deaths. However, when looking at the incidence rate of lung cancer, Hungary had the highest for both males and females, with 138.4 and 72.3 cases per 100,000 population, respectively.
Breast cancer
Breast cancer is the most common type of cancer among women with an incidence rate of 83.3 cases per 100,000 population in Europe in 2022. Cyprus was the country with the highest incidence of breast cancer, followed by Belgium and France. The mortality rate due to breast cancer was 34.8 deaths per 100,000 population across Europe, and Cyprus was again the country with the highest figure.
In 2022, the country with the highest age-standardized cancer incidence rate in Latin America and the Caribbean was Uruguay, with 279.9 new cases per 100,000 population. Cuba and Argentina followed, with cancer incidence rates of 220.8 and 215.8, respectively. In that year, Uruguay was also the country with the highest cancer mortality rate in the region.
In 2022, Australia had the fourth-highest total number of skin cancer cases worldwide and the highest age-standardized rate, with roughly 37 cases of skin cancer per 100,000 population. The graph illustrates the rate of skin cancer in the countries with the highest skin cancer rates worldwide in 2022.
In a recent report it was shown that the U.S. has the highest prevalence of diagnosed cancer cases among all adults, with around 9 percent of the adult population having some cancer diagnosis. Cancer is the second leading cause of death from chronic diseases worldwide after cardiovascular diseases.
Global cancer risks
Globally, cancer accounts for about 1 in every 6 deaths. Many cancer cases are caused by behavioral and dietary risks including tobacco, alcohol and physical inactivity. The prevalence of tobacco smoking is on the decline and is expected to decline further in the future. Smoking has been linked to lung cancer, other upper respiratory cancers and chronic obstructive pulmonary disease (COPD). Among other cancer risk factors, alcohol consumption has been linked to liver and colorectal cancers, as well as other non-communicable diseases. Many European countries have high rates of alcohol consumption.
Global cancer prevalence
Globally, trachea, bronchus and lung cancers are responsible for the most cancer deaths, followed by liver cancer. Lifestyle modification is one of the easiest ways people can reduce their risk of these types of cancer. Among all cancer patients globally, a majority had a history of alcohol consumption. Similarly, in China, EU5 and Russia, over a quarter of all cancer patients had a history of smoking.
In 2022, the highest breast cancer incidence in women in Europe was estimated in Luxembourg with approximately 190 per 100,000 population. Belgium and Cyprus followed closely. The average breast cancer incidence across EU-27 was 147.6 per 100,00 population, in 2022. Cancer incidence in Europe In 2022, Denmark was the European country with the highest cancer incidence, with 728.5 cases per 100,000 population, followed by Ireland and Netherlands, with both around 641 cases per 100,000 people. Overall, the age-standardized incidence rate of cancer in all sites, excluding non-melanoma skin cancers, was 568.7 per 100,000 population in the whole of EU, with the most prevalent type of cancer being prostate cancer, followed by breast and colorectal cancer. Deaths from breast cancer In the same year, breast cancer also had the highest mortality rate among all types of cancers in women, standing at 34.1 deaths per 100,000 females. Cyprus had the highest mortality rate from breast cancer in all of EU with 45.1 deaths per 100,000 women. Meanwhile, the highest number of deaths due to breast cancer in the given year was reported in Germany, where approximately 20.6 thousand women lost their lives to breast cancer.
In 2022, the mortality rate of breast cancer in women in Europe was 34.8 per 100,000 women. Cyprus had the highest mortality rate at 45.1 per 100,000, followed by Slovakia with 44.9 per 100,000 women. Conversely, Spain had the lowest mortality rate at 23.3 per 100,000. This statistic depicts the mortality rate of breast cancer in Europe in 2022 in women population, by country.
In 2022, Uruguay had the highest age-standardized prevalence rate of all cancer types in Latin America and the Caribbean, with 1,316 cases per 100,000 population. Barbados and Cuba followed, with cancer prevalence rates of 1,192.3 and 1,114.8, respectively. That year, Uruguay also had the region's highest mortality death rate.
As of 2018, there were around 133 prostate cancer cases in Ireland per 100,000 men. This was one of the highest rate of prostate cancer worldwide. Prostate cancer is the most common form of cancer among males, although cancer of the lung and bronchus causes the most cancer deaths.
In 2022, the mortality rate of lung cancer in the European was 77.2 per 100,000 men and 32.8 per 100,000 women. Among men the mortality rate was highest in Hungary and lowest in Sweden being 120 and 34.4 per 100,000 respectively. Hungary was also the country with the highest lung cancer mortality rate in women with 61.3 per 100,000 women. The lowest was in Lithuania with 16.4 per 100,000 women. In most EU countries, there was a marked difference between the mortality of lung cancer in men and women.
In 2022, the incidence rate of colorectal cancer in the EU was, among men, 92.7 per 100,000, while among women it stood at 58.2 per 100,000. For men, Hungary had the highest incidence rate at 138.3 per 100,000, while Austria had the lowest at 62.5 per 100,000. For women, Denmark had the highest incidence rate at 95.7 per 100,000, while Austria had the lowest at 37.6 per 100,000. This statistic depicts the incidence rate of colorectal cancer in the EU in 2022, by country and gender (per 100,000 population).
In 2022, the mortality rate of prostate cancer in Europe was 38.6 per 100,000. Estonia had the highest mortality rate at 80.4 per 100,000, followed by Latvia with 76.1 per 100,000 men. Conversely, Italy had the lowest mortality rate at 25.7 per 100,000. This statistic depicts the mortality rate of prostate cancer Europe in 2022, by country.
The 5-year prevalence rate of breast cancer cases in the Middle East and North Africa (MENA) was the highest in Turkey in 2022, followed by Bahrain at about 216 cases per 100,000 cases. Egypt had the highest number of breast cancer cases in the region in 2022.
North America had the highest 12-month cancer prevalence rate in 2022. The 12-month prevalence rate for all cancers in North America as of this time was 595 per 100,000 population. This statistic displays 12-month cancer prevalence rates worldwide in 2022, by region.
In 2022, Australia had the seventh-highest total number of skin cancer cases among women worldwide with 5,917, but the highest age-standardized rate. At that time, the age-standardized rate of skin cancer among women in Australia was around 29 per 100,000 population. This graph displays the rates of skin cancer in women in the countries with the highest total number of skin cancer cases among women worldwide in 2022.
In 2022, the mortality rate of colorectal cancer in Europe was, among men, 42.8 per 100,000, while among women it stood at 24.6 per 100,000. For men, Croatia had the highest mortality rate at 79.3 per 100,000, while Luxembourg had the lowest at 28.2 per 100,000. For women, Croatia also had the highest mortality rate at 36.2 per 100,000, while Austria had the lowest at 17.5 per 100,000. This statistic depicts the mortality rate of colorectal cancer in Europe in 2022, by country and gender.
This statistic depicts cancer incidence rates among men in selected countries worldwide between 2003 and 2007, per 100,000 inhabitants. African American men have one of the highest cancer incidence rates worldwide, with 446.1 new cases per 100,000 inhabitants.
In 2018, Norway reported 50.3 new skin cancer cases per 100,000 population, the highest incidence across Europe. This was followed by an incidence rate of 45.8 cases per 100,000 in Greece. In comparison, 5.7 cases of melanoma were diagnosed in Romania in that year.
In 2018, Hungary reported 111.6 new colorectal cancer cases per 100,000 population, the highest incidence in Europe. This was followed by an incidence rate of 99.8 colorectal cancer cases in Portugal. While in Denmark, 97.1 colorectal cancer cases per 100,000 inhabitants were diagnosed in that year.
This statistic displays the five-year survival rate in children with diagnosed cancer, by selected locations, time periods, and type of cancer. In Australia, children with leukaemias had a five-year chance of survival of over 80 percent in the measured period 1997-2006. In comparison, Chinese children with leukaemias in Shanghai had a chance of little more than 50 percent to survive five years (measured in the period 2002-2005).
In 2022, Poland reported 330.5 deaths from cancer per 100,000 population, the highest cancer mortality rate in Europe. Hungary followed with 327.8 cancer deaths per 100,000, and then Croatia with 319.6 cancer deaths per 100,000 population. This statistic displays the cancer mortality rate in Europe in 2022, by country (per 100,000 population).